-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
New Interim Executive Director at the National Osteoporosis Foundation
Washington, DC - - The National Osteoporosis Foundation (NOF) has named Susan Sarfati, CAE (Certified Association Executives), the new Interim Executive Director of the Foundation. Ms. Sarfati will fill, on an interim basis, the position formerly held by Leo Schargorodski, who recently resigned.
Ms. Sarfati is President of her own speaking and consulting firm focusing on all aspects of organizational strategy. She has served as a key leader in the association and foundation community since 1980. Most recently, she was the founding President & CEO of The Center for Association Leadership and Executive Vice President of The American Society of Association Executives (ASAE).
“I am pleased to serve NOF as Interim Executive Director and to work collaboratively with the Board of Trustees and staff in moving the mission of this vital Foundation forward,” said Sarfati. “I look forward to bringing the experience and expertise from over 25 plus years of leadership in the nonprofit community to the work of NOF and its constituents. NOF is currently celebrating 25 years of service dedicated to making bone health a reality and a lifelong priority for all individuals. We have critical work to do in supporting the vision.”
“The Board of Trustees is pleased to have Ms. Sarfati on board during this critical time,” said NOF Chairman the Honorable Daniel A. Mica. "We thank Mr. Schargorodski for his service and wish him well in the future.” A search is currently underway to select a permanent Executive Director and CEO.
The latest
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
Explore by tag
